首页 | 本学科首页   官方微博 | 高级检索  
检索        

烯二炔类抗肿瘤抗生素单克隆抗体导向药物研究进展
引用本文:李丽,顾觉奋,吴梧桐.烯二炔类抗肿瘤抗生素单克隆抗体导向药物研究进展[J].药物生物技术,2005,12(4):275-277.
作者姓名:李丽  顾觉奋  吴梧桐
作者单位:中国药科大学,生命科学与技术学院,江苏,南京,210009
摘    要:单克隆抗体对相应的抗原有高度特异性。因此,利用单抗作为特异性载体制成导向药物(免疫偶联物),对于治疗肿瘤有巨大潜力和引人瞩目的前景。文章对烯二炔类抗肿瘤抗生素.特别对新制癌菌素、力达霉素和calicheamicins及其单克隆抗体免疫偶联物的研究进展作了概述。

关 键 词:单克降抗体  烯二炔类  抗肿瘤抗生素  免疫偶联物  导向药物
文章编号:1005-8915(2005)04-0275-03
收稿时间:2004-09-23
修稿时间:2004-09-232004-10-18

Advances in Monoclonal Antibody Targeting Drugs of the Antitumor Antibiotics of Enediyne
LI Li,GU Jue-fen,WU Wu-tong.Advances in Monoclonal Antibody Targeting Drugs of the Antitumor Antibiotics of Enediyne[J].Pharmaceutical Biotechnology,2005,12(4):275-277.
Authors:LI Li  GU Jue-fen  WU Wu-tong
Abstract:Monoclonal antibody (McAb) was highly specific- to its antigen. Therefore, it was very attractive to explore the possible use of McAb and its conjugate for cancer treatment. The antitumor antibiotics of enediyne including neocarzinostatin, lidamycin. calicheamicins and their monoclonal antibody immunoconjugate were specifically summarized.
Keywords:Monoclonal antibody  Enediyne  Antitumor antibiotics  Immunoconjugate mylotarg  Targeting drugs
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号